|
US8450112B2
(en)
|
2008-04-09 |
2013-05-28 |
Maxcyte, Inc. |
Engineering and delivery of therapeutic compositions of freshly isolated cells
|
|
CN107880136B
(zh)
|
2010-09-21 |
2021-11-12 |
阿尔托生物科学有限公司 |
多聚体il-15可溶性融合分子与其制造与使用方法
|
|
US9752113B2
(en)
|
2012-03-15 |
2017-09-05 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10322949B2
(en)
|
2012-03-15 |
2019-06-18 |
Flodesign Sonics, Inc. |
Transducer and reflector configurations for an acoustophoretic device
|
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US9950282B2
(en)
|
2012-03-15 |
2018-04-24 |
Flodesign Sonics, Inc. |
Electronic configuration and control for acoustic standing wave generation
|
|
US10689609B2
(en)
|
2012-03-15 |
2020-06-23 |
Flodesign Sonics, Inc. |
Acoustic bioreactor processes
|
|
US9745548B2
(en)
|
2012-03-15 |
2017-08-29 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10967298B2
(en)
|
2012-03-15 |
2021-04-06 |
Flodesign Sonics, Inc. |
Driver and control for variable impedence load
|
|
US9458450B2
(en)
|
2012-03-15 |
2016-10-04 |
Flodesign Sonics, Inc. |
Acoustophoretic separation technology using multi-dimensional standing waves
|
|
US10737953B2
(en)
|
2012-04-20 |
2020-08-11 |
Flodesign Sonics, Inc. |
Acoustophoretic method for use in bioreactors
|
|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
EP2948544A4
(en)
|
2013-01-28 |
2016-08-03 |
St Jude Childrens Res Hospital |
CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR CELL THERAPY AGAINST CANCER AND INFECTION DISEASES
|
|
US20150064153A1
(en)
|
2013-03-15 |
2015-03-05 |
The Trustees Of Princeton University |
High efficiency microfluidic purification of stem cells to improve transplants
|
|
EP3569313A1
(en)
|
2013-03-15 |
2019-11-20 |
GPB Scientific, LLC |
On-chip microfluidic processing of particles
|
|
EP3608022A1
(en)
|
2013-03-15 |
2020-02-12 |
The Trustees of Princeton University |
Methods and devices for high throughput purification
|
|
US12590955B2
(en)
|
2013-03-15 |
2026-03-31 |
Zeon Corporation |
Methods and systems for processing particles
|
|
EP3783098A1
(en)
|
2013-05-14 |
2021-02-24 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
AU2014268364A1
(en)
|
2013-05-24 |
2015-12-10 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
US9745569B2
(en)
|
2013-09-13 |
2017-08-29 |
Flodesign Sonics, Inc. |
System for generating high concentration factors for low cell density suspensions
|
|
WO2015105955A1
(en)
|
2014-01-08 |
2015-07-16 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
US11028143B2
(en)
|
2014-01-21 |
2021-06-08 |
Novartis Ag |
Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules
|
|
WO2015120187A1
(en)
|
2014-02-05 |
2015-08-13 |
The University Of Chicago |
Chimeric antigen receptors recognizing cancer-spevific tn glycopeptide variants
|
|
EP3656864A1
(en)
|
2014-02-14 |
2020-05-27 |
Board of Regents, The University of Texas System |
Chimeric antigen receptors and methods of making
|
|
CA2945320A1
(en)
|
2014-04-10 |
2015-10-15 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Drug regulated transgene expression
|
|
RU2763795C2
(ru)
|
2014-04-23 |
2022-01-11 |
Джуно Терапьютикс, Инк. |
Способы выделения, культивирования и генетической инженерии популяций клеток иммунной системы для адоптивной терапии
|
|
AU2015259877B2
(en)
|
2014-05-15 |
2021-02-25 |
National University Of Singapore |
Modified natural killer cells and uses thereof
|
|
CA3151221C
(en)
*
|
2014-06-30 |
2026-01-13 |
Altor Bioscience Corporation |
Il-15-based molecules and methods of use thereof
|
|
US9744483B2
(en)
|
2014-07-02 |
2017-08-29 |
Flodesign Sonics, Inc. |
Large scale acoustic separation device
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
KR20170037625A
(ko)
|
2014-07-21 |
2017-04-04 |
노파르티스 아게 |
Cll-1 키메라 항원 수용체를 사용한 암의 치료
|
|
SG10201913765YA
(en)
|
2014-07-21 |
2020-03-30 |
Novartis Ag |
Treatment of cancer using a cd33 chimeric antigen receptor
|
|
TWI750110B
(zh)
|
2014-07-21 |
2021-12-21 |
瑞士商諾華公司 |
使用人類化抗-ｂｃｍａ嵌合抗原受體治療癌症
|
|
ES2753391T3
(es)
|
2014-10-14 |
2020-04-08 |
Halozyme Inc |
Composiciones de adenosina desaminasa 2 (ADA2), variantes de la misma y métodos de uso de las mismas
|
|
CA2964783C
(en)
|
2014-11-05 |
2024-01-23 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) to selectively target protein complexes
|
|
US20180021378A1
(en)
*
|
2014-12-31 |
2018-01-25 |
Anthrogenesis Corporation |
Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
|
|
US20180148480A1
(en)
*
|
2015-01-16 |
2018-05-31 |
The Johns Hopkins University |
Synthetic enhancement of the t-cell armamentarium as an anti-cancer therapy
|
|
US10377988B2
(en)
|
2015-01-23 |
2019-08-13 |
Musc Foundation For Research Development |
Cytokine receptor genes and the use thereof to enhance therapy
|
|
WO2016123143A1
(en)
|
2015-01-26 |
2016-08-04 |
The University Of Chicago |
CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13Rα2
|
|
JP7264592B2
(ja)
|
2015-01-26 |
2023-04-25 |
ザ ユニバーシティー オブ シカゴ |
ＩＬ１３Ｒα２結合剤及び癌治療におけるその使用
|
|
ES2857998T3
(es)
*
|
2015-02-12 |
2021-09-29 |
Univ Health Network |
Receptores de antígenos quiméricos
|
|
EP3804741A3
(en)
|
2015-02-24 |
2021-07-14 |
Board of Regents, The University of Texas System |
Selection methods for genetically-modified t cells
|
|
KR102615825B1
(ko)
*
|
2015-03-11 |
2023-12-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
전위효소 폴리펩타이드 및 이의 용도
|
|
SG11201708516YA
(en)
|
2015-04-17 |
2017-11-29 |
David Maxwell Barrett |
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells
|
|
US11021699B2
(en)
|
2015-04-29 |
2021-06-01 |
FioDesign Sonics, Inc. |
Separation using angled acoustic waves
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
GB201507368D0
(en)
*
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
US10639329B2
(en)
*
|
2015-06-12 |
2020-05-05 |
Lentigen Technology, Inc. |
Method to treat cancer with engineered T-cells
|
|
TWI833684B
(zh)
*
|
2015-06-25 |
2024-03-01 |
美商生物細胞基因治療有限公司 |
嵌合抗原受體（ｃａｒ）、組合物及其使用方法
|
|
JP7057748B2
(ja)
*
|
2015-07-16 |
2022-04-20 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
遺伝子改変された抗第三者中枢性メモリーｔ細胞および免疫療法におけるその使用
|
|
AU2016297014B2
(en)
|
2015-07-21 |
2021-06-17 |
Novartis Ag |
Methods for improving the efficacy and expansion of immune cells
|
|
US11459540B2
(en)
|
2015-07-28 |
2022-10-04 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
US11474085B2
(en)
|
2015-07-28 |
2022-10-18 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
EP3328994A4
(en)
*
|
2015-07-31 |
2019-04-17 |
Memorial Sloan-Kettering Cancer Center |
CD56-Faced Antigen-Binding Proteins and Uses Thereof
|
|
US10976232B2
(en)
|
2015-08-24 |
2021-04-13 |
Gpb Scientific, Inc. |
Methods and devices for multi-step cell purification and concentration
|
|
ES2980794T3
(es)
|
2015-09-15 |
2024-10-03 |
Acerta Pharma Bv |
Combinaciones terapéuticas de un inhibidor de CD19 y un inhibidor de BTK
|
|
US10633445B2
(en)
|
2015-09-15 |
2020-04-28 |
Board Of Regents The University Of Texas System |
T-cell receptor (TCR)-binding antibodies and uses thereof
|
|
US11059879B2
(en)
|
2015-10-27 |
2021-07-13 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
MX2018005274A
(es)
|
2015-10-30 |
2019-09-19 |
The Regents Of The Universtiy Of California |
Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
|
|
US10691773B2
(en)
|
2015-12-30 |
2020-06-23 |
General Electric Company |
Cell processing techniques
|
|
WO2017123548A1
(en)
*
|
2016-01-14 |
2017-07-20 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Tumor-specific ifna secretion by car t-cells to reprogram the solid tumor microenvironment
|
|
US20200063157A9
(en)
*
|
2016-02-26 |
2020-02-27 |
Poseida Therapeutics, Inc. |
Transposon system and methods of use
|
|
US11325948B2
(en)
|
2016-03-19 |
2022-05-10 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
|
|
US12590321B2
(en)
|
2016-03-19 |
2026-03-31 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying and expanding lymphocytes and regulating the activity thereof
|
|
IL261713B2
(en)
*
|
2016-03-19 |
2023-09-01 |
F1 Oncology Inc |
Methods and preparations for the transfer of lymphocytes and their regulated expansion
|
|
US11111505B2
(en)
|
2016-03-19 |
2021-09-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
PT3436079T
(pt)
|
2016-04-01 |
2021-10-06 |
Kite Pharma Inc |
Recetores de antigénios quiméricos e de células t e métodos de uso
|
|
CN109414455B
(zh)
|
2016-04-01 |
2023-01-20 |
凯德药业股份有限公司 |
Bcma结合分子及其使用方法
|
|
KR20200068750A
(ko)
|
2016-04-01 |
2020-06-15 |
카이트 파마 인코포레이티드 |
키메라 수용체 및 그의 사용 방법
|
|
JP7282521B2
(ja)
|
2016-04-08 |
2023-05-29 |
パーデュー・リサーチ・ファウンデイション |
Ｃａｒ ｔ細胞療法のための方法および組成物
|
|
EP3443001B1
(en)
|
2016-04-11 |
2025-04-30 |
Obsidian Therapeutics, Inc. |
REGULATED BIOCIRCUIT SYSTEMS
|
|
US10188749B2
(en)
|
2016-04-14 |
2019-01-29 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
US11377637B2
(en)
|
2016-04-15 |
2022-07-05 |
Memorial Sloan Kettering Cancer Center |
Transgenic T cell and chimeric antigen receptor T cell compositions and related methods
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
US11085035B2
(en)
|
2016-05-03 |
2021-08-10 |
Flodesign Sonics, Inc. |
Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
|
|
CN105968210B
(zh)
*
|
2016-05-13 |
2019-05-31 |
深圳生创精准医疗科技有限公司 |
靶向cd22的强杀伤性嵌合抗原受体t细胞及其在制备治疗肿瘤的药物中的用途
|
|
MX2018014991A
(es)
*
|
2016-06-03 |
2019-08-29 |
Memorial Sloan Kettering Cancer Center |
Terapias adoptivas de celulas como opciones de tratamiento temprano.
|
|
SG11201810640RA
(en)
|
2016-06-08 |
2018-12-28 |
Intrexon Corp |
Cd33 specific chimeric antigen receptors
|
|
JP7185530B2
(ja)
|
2016-06-13 |
2022-12-07 |
トルク セラピューティクス， インコーポレイテッド |
免疫細胞機能を促進するための方法および組成物
|
|
JP7114490B2
(ja)
*
|
2016-06-24 |
2022-08-08 |
アイセル・ジーン・セラピューティクス・エルエルシー |
キメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法
|
|
AU2017299854A1
(en)
*
|
2016-07-18 |
2019-01-31 |
Helix Biopharma Corp. |
CAR immune cells directed to carcinoembryonic antigen related cell adhesion molecule 6 to treat cancer
|
|
CN109804246B
(zh)
*
|
2016-08-01 |
2022-05-17 |
健康研究公司 |
用于快速克隆t细胞受体的组合物和方法
|
|
CN106222201B
(zh)
*
|
2016-08-27 |
2017-11-28 |
北京艺妙神州医疗科技有限公司 |
一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用
|
|
SG11201901959YA
(en)
*
|
2016-09-30 |
2019-04-29 |
Poseida Therapeutics Inc |
Modified stem cell memory t cells, methods of making and methods of using same
|
|
US20190119636A1
(en)
|
2017-10-23 |
2019-04-25 |
Poseida Therapeutics, Inc. |
Modified stem cell memory t cells, methods of making and methods of using same
|
|
BR112019006652A2
(pt)
|
2016-10-13 |
2019-07-02 |
Juno Therapeutics Inc |
métodos e composições para imunoterapia envolvendo moduladores da via metabólica do triptofano
|
|
CA3041517A1
(en)
|
2016-10-19 |
2018-04-26 |
Flodesign Sonics, Inc. |
Affinity cell extraction by acoustics
|
|
US20190290728A1
(en)
*
|
2016-10-21 |
2019-09-26 |
Children's Medical Center Corporation |
Methods related to breaking t cell exhaustion
|
|
WO2018102761A1
(en)
*
|
2016-12-02 |
2018-06-07 |
City Of Hope |
Methods for manufacturing and expanding t cells expressing chimeric antigen receptors and other receptors
|
|
CN110352068A
(zh)
|
2016-12-02 |
2019-10-18 |
南加利福尼亚大学 |
合成的免疫受体及其使用方法
|
|
AU2017378482B2
(en)
|
2016-12-16 |
2024-06-13 |
R&D Systems, Inc. |
Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
|
|
US11278570B2
(en)
|
2016-12-16 |
2022-03-22 |
B-Mogen Biotechnologies, Inc. |
Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
|
|
GB201621889D0
(en)
*
|
2016-12-21 |
2017-02-01 |
Autolus Ltd |
Cell
|
|
WO2018124766A2
(ko)
|
2016-12-28 |
2018-07-05 |
주식회사 녹십자랩셀 |
키메라 항원 수용체 및 이를 발현하는 자연 살해 세포
|
|
CN108250301A
(zh)
*
|
2016-12-29 |
2018-07-06 |
天津天锐生物科技有限公司 |
一种多靶点嵌合抗原受体
|
|
JP7348063B2
(ja)
|
2017-01-05 |
2023-09-20 |
フレッド ハッチンソン キャンサー センター |
ワクチン効力を改善するためのシステム及び方法
|
|
JP2020504623A
(ja)
*
|
2017-01-05 |
2020-02-13 |
へリックス バイオファーマ コープ． |
癌を治療するためのｖｅｇｆｒ−２ ｃａｒ免疫細胞
|
|
KR20190102259A
(ko)
|
2017-01-10 |
2019-09-03 |
인트렉손 코포레이션 |
신규의 유전자 스위치 발현 시스템을 통한 폴리펩티드의 발현 조절
|
|
SG10202107808SA
(en)
*
|
2017-01-18 |
2021-08-30 |
F1 Oncology Inc |
Chimeric antigen receptors against axl or ror2 and methods of use thereof
|
|
CN110612119B
(zh)
|
2017-02-07 |
2024-10-29 |
西雅图儿童医院（Dba西雅图儿童研究所） |
磷脂醚(ple)car t细胞肿瘤靶向(ctct)剂
|
|
JP7178355B2
(ja)
|
2017-02-28 |
2022-11-25 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞療法のための組成物および方法
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
AU2018226884B2
(en)
*
|
2017-03-03 |
2024-11-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereof
|
|
KR102746901B1
(ko)
*
|
2017-03-03 |
2024-12-26 |
옵시디안 테라퓨틱스, 인크. |
Cd19 조성물 및 면역요법을 위한 방법
|
|
WO2018169922A2
(en)
|
2017-03-13 |
2018-09-20 |
Kite Pharma, Inc. |
Chimeric antigen receptors for melanoma and uses thereof
|
|
MX2019011570A
(es)
|
2017-03-27 |
2019-11-18 |
Nat Univ Singapore |
Lineas celulares estimuladoras para expansion y activacion ex vivo de celulas asesinas naturales.
|
|
KR102660336B1
(ko)
|
2017-03-27 |
2024-04-26 |
내셔널 유니버시티 오브 싱가포르 |
절단된 nkg2d 키메라 수용체 및 자연 살해 세포 면역요법에서의 그의 용도
|
|
WO2018183888A2
(en)
|
2017-03-31 |
2018-10-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of treating t cell exhaustion by inhibiting or modulating t cell receptor signaling
|
|
MX2019012295A
(es)
*
|
2017-04-14 |
2020-02-07 |
Tollnine Inc |
Polinucleotidos inmunomoduladores, conjugados de anticuerpos de los mismos y metodos para su uso.
|
|
WO2018195175A1
(en)
*
|
2017-04-18 |
2018-10-25 |
FUJIFILM Cellular Dynamics, Inc. |
Antigen-specific immune effector cells
|
|
WO2018195339A1
(en)
*
|
2017-04-19 |
2018-10-25 |
Board Of Regents, The University Of Texas System |
Immune cells expressing engineered antigen receptors
|
|
SG10201912400VA
(en)
|
2017-04-24 |
2020-02-27 |
Kite Pharma Inc |
Humanized antigen-binding domains against cd19 and methods of use
|
|
US12384830B2
(en)
|
2017-06-02 |
2025-08-12 |
Regents Of The University Of Minnesota |
Compositions and methods for improving immunotherapy
|
|
CN110996974A
(zh)
|
2017-06-16 |
2020-04-10 |
梅约医学教育与研究基金会 |
增加免疫应答的材料和方法
|
|
CA3287539A1
(en)
|
2017-06-21 |
2026-03-02 |
Icell Gene Therapeutics Llc |
CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF
|
|
CA3068286A1
(en)
*
|
2017-06-22 |
2018-12-27 |
Board Of Regents, The University Of Texas System |
Methods for producing regulatory immune cells and uses thereof
|
|
CN111432823A
(zh)
*
|
2017-07-25 |
2020-07-17 |
得克萨斯大学体系董事会 |
增强的嵌合抗原受体及其用途
|
|
CN109337872B
(zh)
*
|
2017-07-27 |
2023-06-23 |
上海细胞治疗研究院 |
高效扩增car-t细胞的人工抗原递呈细胞及其用途
|
|
CN111263641B
(zh)
*
|
2017-08-09 |
2025-10-31 |
朱诺治疗学股份有限公司 |
用于制备基因工程化细胞的方法和组合物
|
|
EP3675876A4
(en)
|
2017-09-01 |
2021-06-02 |
GPB Scientific, Inc. |
METHOD FOR PRODUCING THERAPEUTICALLY ACTIVE CELLS USING MICROFLUIDICS
|
|
CA3248436A1
(en)
|
2017-09-01 |
2025-02-21 |
Lonza Walkersville, Inc. |
END-TO-END AUTOMATION OF CELL THERAPY
|
|
JP7285828B2
(ja)
|
2017-09-05 |
2023-06-02 |
トルク セラピューティクス， インコーポレイテッド |
治療用タンパク質組成物ならびにその作製および使用方法
|
|
CN111479921B
(zh)
*
|
2017-09-18 |
2024-08-02 |
埃克苏马生物技术公司 |
用于以基因方式修饰且扩增淋巴细胞以及调节其活性的方法及组合物
|
|
US11905528B2
(en)
|
2017-10-12 |
2024-02-20 |
Icell Gene Therapeutics Inc. |
Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof
|
|
EP3697438A4
(en)
|
2017-10-18 |
2021-08-18 |
Intrexon Corporation |
POLYPEPTIDE COMPOSITIONS WITH SPACERS
|
|
KR20200085780A
(ko)
|
2017-11-07 |
2020-07-15 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
암의 치료에서 car-t 또는 car-nk 세포를 사용한 lilrb4 표적화
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
IL274677B2
(en)
*
|
2017-11-14 |
2025-01-01 |
Arcellx Inc |
Therapies with multifunctional immune system cells
|
|
US12116417B2
(en)
|
2017-11-14 |
2024-10-15 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
EP3710020A4
(en)
|
2017-11-14 |
2021-06-23 |
Memorial Sloan-Kettering Cancer Center |
IL-36 SECRETING IMMUNE RESPONSIVE CELLS AND USES THEREOF
|
|
WO2019099707A1
(en)
|
2017-11-16 |
2019-05-23 |
Kite Pharma, Inc |
Modified chimeric antigen receptors and methods of use
|
|
CN107974460B
(zh)
*
|
2017-11-30 |
2021-06-01 |
山东兴瑞生物科技有限公司 |
针对hiv-1的嵌合抗原受体基因、具有该基因的质粒、t细胞、试剂盒及应用
|
|
WO2019118921A1
(en)
|
2017-12-14 |
2019-06-20 |
Flodesign Sonics, Inc. |
Acoustic transducer drive and controller
|
|
CN108251376B
(zh)
*
|
2017-12-21 |
2021-08-13 |
王文举 |
人工抗原递呈细胞及其构建方法与在嵌合抗原受体t细胞扩增中的应用
|
|
CU24545B1
(es)
*
|
2017-12-29 |
2021-09-07 |
Ct Ingenieria Genetica Biotecnologia |
Péptido antagonista de la actividad de la interleucina-15
|
|
US12491153B2
(en)
|
2018-01-03 |
2025-12-09 |
Qu Biologics Inc. |
Innate targeting of adoptive cellular therapies
|
|
JP2021509903A
(ja)
*
|
2018-01-05 |
2021-04-08 |
マックスサイト インコーポレーティッド |
癌の長期ｃａｒ処置
|
|
CN111629715A
(zh)
|
2018-01-18 |
2020-09-04 |
弗莱德哈钦森癌症研究中心 |
通过调节细胞活化状态改变体内免疫细胞的炎症状态
|
|
JP7549303B2
(ja)
|
2018-01-22 |
2024-09-11 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞の使用方法
|
|
WO2019147604A2
(en)
*
|
2018-01-23 |
2019-08-01 |
Vanderbilt University |
Self-antigen specific t-cells as vacines for augmenting engraftment and stability of autologous transfer
|
|
CN110093351B
(zh)
*
|
2018-01-29 |
2023-06-23 |
华南生物医药研究院 |
可分离的核酸、多肽、重组载体、重组细胞及应用
|
|
SG11202007426XA
(en)
|
2018-02-06 |
2020-09-29 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
|
|
AU2019219454A1
(en)
|
2018-02-09 |
2020-08-27 |
National University Of Singapore |
Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
EP3749753B1
(en)
|
2018-02-09 |
2025-04-02 |
Immatics US, Inc. |
Methods for manufacturing t cells
|
|
WO2019160956A1
(en)
*
|
2018-02-13 |
2019-08-22 |
Novartis Ag |
Chimeric antigen receptor therapy in combination with il-15r and il15
|
|
CN112534044A
(zh)
|
2018-02-16 |
2021-03-19 |
凯德药业股份有限公司 |
经修饰的多能干细胞及制备和使用方法
|
|
JP7273421B2
(ja)
|
2018-02-21 |
2023-05-15 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
|
|
CN112105382A
(zh)
|
2018-02-23 |
2020-12-18 |
恩多塞特公司 |
用于car t细胞疗法的顺序方法
|
|
WO2019178078A1
(en)
*
|
2018-03-14 |
2019-09-19 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Il-13 receptor alpha 2 (il13ra2) chimeric antigen receptor for tumor specific t cell immunotherapy
|
|
SG11202008926RA
(en)
|
2018-03-14 |
2020-10-29 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Il-13 receptor alpha 2 targeted, zetakine directed t cell immunotherapy
|
|
CN112055717B
(zh)
|
2018-04-02 |
2024-04-26 |
新加坡国立大学 |
用在免疫细胞中表达的膜结合抗细胞因子非信号传导粘合剂中和人细胞因子
|
|
CA3096202A1
(en)
|
2018-04-06 |
2019-10-10 |
The Regents Of The University Of California |
Methods of treating egfrviii expressing glioblastomas
|
|
CA3095757A1
(en)
|
2018-04-06 |
2019-10-10 |
The Regents Of The University Of California |
Methods of treating glioblastomas
|
|
US10869888B2
(en)
|
2018-04-17 |
2020-12-22 |
Innovative Cellular Therapeutics CO., LTD. |
Modified cell expansion and uses thereof
|
|
JP2021523110A
(ja)
*
|
2018-05-01 |
2021-09-02 |
フレッド ハッチンソン キャンサー リサーチ センター |
遺伝子発現のためのナノ粒子及びその使用
|
|
AR126019A1
(es)
|
2018-05-30 |
2023-09-06 |
Novartis Ag |
Anticuerpos frente a entpd2, terapias de combinación y métodos de uso de los anticuerpos y las terapias de combinación
|
|
US11319380B2
(en)
*
|
2018-06-04 |
2022-05-03 |
Precigen, Inc. |
MUC16 specific chimeric antigen receptors and uses thereof
|
|
CA3103233A1
(en)
*
|
2018-06-12 |
2019-12-19 |
APDN (B.V.I.), Inc. |
Engineered lymphocyte compositions, methods and systems
|
|
WO2019241315A1
(en)
|
2018-06-12 |
2019-12-19 |
Obsidian Therapeutics, Inc. |
Pde5 derived regulatory constructs and methods of use in immunotherapy
|
|
CA3100724A1
(en)
|
2018-06-13 |
2019-12-19 |
Novartis Ag |
B-cell maturation antigen protein (bcma) chimeric antigen receptors and uses thereof
|
|
AU2019288669B2
(en)
|
2018-06-21 |
2025-06-26 |
R&D Systems, Inc. |
Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
|
|
WO2020014285A2
(en)
|
2018-07-09 |
2020-01-16 |
Intrexon Corporation |
Fusion constructs and methods of using thereof
|
|
EP3820484A4
(en)
|
2018-07-10 |
2022-05-04 |
Precigen, Inc. |
ROR-1 SPECIFIC CHIMERA ANTIGEN RECEPTORS AND USES THEREOF
|
|
JP2021530212A
(ja)
*
|
2018-07-13 |
2021-11-11 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California |
レトロトランスポゾンベースの送達媒体及びその使用方法
|
|
CN113474450A
(zh)
|
2018-08-09 |
2021-10-01 |
朱诺治疗学股份有限公司 |
产生工程化细胞的方法以及所述工程化细胞的组合物
|
|
CN108949695A
(zh)
*
|
2018-08-14 |
2018-12-07 |
杭州荣泽生物科技有限公司 |
一种非病毒载体共表达il18的car-t细胞构建及其应用
|
|
WO2020037142A1
(en)
|
2018-08-17 |
2020-02-20 |
Yale University |
Compositions and methods for high-throughput activation screening to boost t cell effector function
|
|
CN110862967A
(zh)
*
|
2018-08-27 |
2020-03-06 |
天津天锐生物科技有限公司 |
一种不依赖细胞因子培养的自然杀伤细胞系silk-nk
|
|
EP3844186A4
(en)
|
2018-08-29 |
2022-08-17 |
National University of Singapore |
METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
|
|
US12240915B2
(en)
|
2018-08-30 |
2025-03-04 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Chimeric antigen receptor cells for treating solid tumor
|
|
BR112021003640A2
(pt)
|
2018-08-31 |
2021-05-18 |
Noile-Immune Biotech, Inc. |
célula t, medicamento, vetor de expressão, e, métodos para produzir uma célula de t car e para tratar câncer
|
|
EP3847197A1
(en)
*
|
2018-09-05 |
2021-07-14 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|
|
CN109320615B
(zh)
*
|
2018-09-25 |
2023-09-22 |
上海恒润达生生物科技股份有限公司 |
靶向新型bcma的嵌合抗原受体及其用途
|
|
JP7396777B2
(ja)
|
2018-09-28 |
2023-12-12 |
オクタン バイオテック インコーポレーテッド |
磁気分離
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
US11701408B2
(en)
*
|
2018-10-11 |
2023-07-18 |
Nantcell, Inc. |
Treatment of immunosuppressed subjects
|
|
WO2020086742A1
(en)
|
2018-10-24 |
2020-04-30 |
Obsidian Therapeutics, Inc. |
Er tunable protein regulation
|
|
WO2020092696A1
(en)
*
|
2018-10-31 |
2020-05-07 |
Musc Foundation For Research Development |
Ex vivo activation and expansion of t cells for adoptive cell transfer therapy
|
|
CN111197032A
(zh)
*
|
2018-11-16 |
2020-05-26 |
上海斯丹赛生物技术有限公司 |
嵌合抗原受体细胞分泌治疗剂
|
|
US10918667B2
(en)
|
2018-11-20 |
2021-02-16 |
Innovative Cellular Therapeutics CO., LTD. |
Modified cell expressing therapeutic agent and uses thereof
|
|
EP3883585A4
(en)
*
|
2018-11-20 |
2022-12-14 |
Innovative Cellular Therapeutics Holdings, Ltd. |
MODIFIED CELL EXPRESSING THERAPEUTIC AND USES THEREOF
|
|
US12590148B2
(en)
|
2018-11-26 |
2026-03-31 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
JP2022513164A
(ja)
*
|
2018-11-30 |
2022-02-07 |
セルラリティ インク． |
胎盤由来同種ｃａｒ－ｔ細胞およびその使用
|
|
KR102840400B1
(ko)
|
2018-12-12 |
2025-08-04 |
카이트 파마 인코포레이티드 |
키메라 항원 수용체 및 car-t 세포 및 사용 방법
|
|
KR20210108406A
(ko)
|
2018-12-21 |
2021-09-02 |
론자 워커스빌 아이엔씨. |
바이러스 벡터의 자동화된 생산
|
|
IL284214B2
(en)
|
2018-12-21 |
2025-03-01 |
Octane Biotech Inc |
Carousel for modular biologic production units
|
|
WO2020163682A1
(en)
|
2019-02-07 |
2020-08-13 |
Board Of Regents, The University Of Texas System |
Glucuronoxylomannan (gxm) receptor chimeric antigen receptors and use thereof
|
|
CA3132872A1
(en)
|
2019-02-07 |
2020-08-13 |
Board Of Regents, The University Of Texas System |
Aspergillus antigen chimeric receptors and use thereof
|
|
IL285288B2
(en)
|
2019-02-08 |
2026-04-01 |
Lonza Walkersville Inc |
Cell concentration methods and devices for use in automated bioreactors
|
|
AU2020232691B2
(en)
*
|
2019-03-05 |
2023-06-29 |
Nkarta, Inc. |
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
|
|
CN114026123A
(zh)
*
|
2019-03-22 |
2022-02-08 |
光点治疗公司 |
靶向活性基因编辑剂及使用方法
|
|
KR20210150446A
(ko)
*
|
2019-04-04 |
2021-12-10 |
상하이 파마슈티컬스 홀딩 컴퍼니 리미티드 |
종양 항원 인식 수용체를 함유하는 면역 세포 및 이의 적용
|
|
JP2022526843A
(ja)
|
2019-04-12 |
2022-05-26 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
制御性ｂ細胞の産生方法およびその使用
|
|
US20220267726A1
(en)
|
2019-07-18 |
2022-08-25 |
Gpb Scientific, Inc. |
Ordered processing of blood products to produce therapeutically active cells
|
|
US20220268762A1
(en)
*
|
2019-07-28 |
2022-08-25 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Methods, systems, and computer-readable media for predicting a cancer patient's response to immune-based or targeted therapy
|
|
WO2021019706A1
(ja)
*
|
2019-07-31 |
2021-02-04 |
国立大学法人信州大学 |
Ｃａｒ発現免疫細胞を含む細胞集団の製造方法
|
|
US12116578B2
(en)
|
2019-08-07 |
2024-10-15 |
APDN (B.V.1.) 1nc. |
Methods and systems of PCR-based recombinant adeno-associated virus manufacture
|
|
US20230092895A1
(en)
|
2019-08-30 |
2023-03-23 |
Obsidian Therapeutics, Inc. |
Tandem cd19 car-based compositions and methods for immunotherapy
|
|
WO2021046451A1
(en)
|
2019-09-06 |
2021-03-11 |
Obsidian Therapeutics, Inc. |
Compositions and methods for dhfr tunable protein regulation
|
|
CA3150224A1
(en)
|
2019-09-10 |
2021-03-18 |
Obsidian Therapeutics, Inc. |
Ca2 compositions and methods for tunable regulation
|
|
US20220348651A1
(en)
|
2019-09-18 |
2022-11-03 |
Novartis Ag |
Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapies
|
|
JP2022554217A
(ja)
*
|
2019-10-23 |
2022-12-28 |
ザ・カウンシル・オヴ・ザ・クイーンズランド・インスティテュート・オヴ・メディカル・リサーチ |
養子免疫療法
|
|
CN114729292A
(zh)
|
2019-10-24 |
2022-07-08 |
奥克泰生物科技股份有限公司 |
具有经改进的细胞接触表面的细胞培养室
|
|
EP4058563A4
(en)
|
2019-11-11 |
2023-12-06 |
Lonza Walkersville, Inc. |
QUALITY CONTROL PROCEDURES FOR AUTOMATED CELL PROCESSING
|
|
IL292924A
(en)
|
2019-11-26 |
2022-07-01 |
Novartis Ag |
Chimeric antigen receptors cd19 and cd22 and their uses
|
|
CN115315434A
(zh)
*
|
2019-12-05 |
2022-11-08 |
免疫靶向有限公司 |
白细胞介素15融合蛋白和前药及其组合物和方法
|
|
BR112022012112A2
(pt)
*
|
2019-12-20 |
2022-09-06 |
Regeneron Pharma |
Agonistas de il2 e métodos de uso dos mesmos
|
|
US20230028754A1
(en)
|
2019-12-28 |
2023-01-26 |
Gpb Scientific, Inc. |
Microfluidic cartridges for processing particles and cells
|
|
AU2021217003A1
(en)
|
2020-02-04 |
2022-09-15 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Anti-dinitrophenol chimeric antigen receptors
|
|
US20230079539A1
(en)
|
2020-02-10 |
2023-03-16 |
Board Of Regents, The University Of Texas System |
Methods for rapid cloning and expression of hla class i cells
|
|
US12076343B2
(en)
|
2020-02-19 |
2024-09-03 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Engineered safety in cell therapy
|
|
TW202144400A
(zh)
*
|
2020-02-20 |
2021-12-01 |
美商凱特製藥公司 |
嵌合抗原受體t細胞療法
|
|
JP2023518281A
(ja)
|
2020-03-19 |
2023-04-28 |
ヴァスキュラー バイオサイエンスィズ |
コロナウイルス生存率改善のためのｃａｒペプチド
|
|
US12091681B2
(en)
*
|
2020-03-27 |
2024-09-17 |
Mendus B.V. |
Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
|
|
CA3173480A1
(en)
*
|
2020-03-31 |
2021-10-07 |
Kathleen Boyle |
Modified b cells and methods of use thereof
|
|
EP4127188A4
(en)
|
2020-03-31 |
2024-08-21 |
Walking Fish Therapeutics |
MODIFIED B CELLS AND METHODS OF USE THEREOF
|
|
US12043654B2
(en)
|
2020-06-02 |
2024-07-23 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Anti-GCC antibody and CAR thereof for treating digestive system cancer
|
|
CN116133679A
(zh)
|
2020-06-30 |
2023-05-16 |
门德斯有限公司 |
白血病衍生细胞在卵巢癌疫苗中的用途
|
|
CN113913459A
(zh)
*
|
2020-07-09 |
2022-01-11 |
杭州优凯瑞医药科技有限公司 |
一种应用非病毒方法制备高纯度嵌合抗原受体修饰的t细胞的方法及其应用
|
|
CN113913458A
(zh)
*
|
2020-07-09 |
2022-01-11 |
杭州优凯瑞医药科技有限公司 |
非病毒方法制备稳定高表达嵌合受体的nk细胞
|
|
EP4178680A4
(en)
|
2020-07-10 |
2024-07-31 |
Precigen, Inc. |
FUSION CONSTRUCTS AND THEIR METHODS OF USE
|
|
CA3195886A1
(en)
*
|
2020-09-17 |
2022-03-24 |
Sunnybay Biotech, Inc |
Herv-k antibody therapeutics
|
|
CA3201499A1
(en)
|
2020-11-13 |
2022-05-19 |
Catamaran Bio, Inc. |
Genetically modified natural killer cells and methods of use thereof
|
|
WO2022115611A1
(en)
|
2020-11-25 |
2022-06-02 |
Catamaran Bio, Inc. |
Cellular therapeutics engineered with signal modulators and methods of use thereof
|
|
US11591381B2
(en)
|
2020-11-30 |
2023-02-28 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
AU2021392032A1
(en)
|
2020-12-03 |
2023-06-22 |
Century Therapeutics, Inc. |
Genetically engineered cells and uses thereof
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
AR124414A1
(es)
|
2020-12-18 |
2023-03-22 |
Century Therapeutics Inc |
Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable
|
|
CA3203180A1
(en)
*
|
2020-12-23 |
2022-06-30 |
Robert Tighe |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
WO2022144632A1
(en)
|
2020-12-30 |
2022-07-07 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into nk cells
|
|
US12234473B2
(en)
|
2020-12-31 |
2025-02-25 |
Immatics US, Inc. |
CD8 polypeptides, compositions, and methods of using thereof
|
|
MX2023008115A
(es)
*
|
2021-01-11 |
2023-09-11 |
Precigen Inc |
Terapia con receptores quiméricos.
|
|
JP2024504585A
(ja)
*
|
2021-01-19 |
2024-02-01 |
オブシディアン セラピューティクス， インコーポレイテッド |
Ｔ細胞及び腫瘍浸潤リンパ球の拡張のための組成物及び方法
|
|
IL305571A
(en)
*
|
2021-03-11 |
2023-10-01 |
Kite Pharma Inc |
Improving the function of immune system cells
|
|
WO2022216144A1
(en)
*
|
2021-04-08 |
2022-10-13 |
GC Cell Corporation |
Fusion proteins comprising chimeric antigen receptors and il-15
|
|
WO2022242644A1
(zh)
*
|
2021-05-18 |
2022-11-24 |
赛斯尔擎生物技术（上海）有限公司 |
修饰细胞的方法
|
|
TW202307210A
(zh)
|
2021-06-01 |
2023-02-16 |
瑞士商諾華公司 |
Ｃｄ１９和ｃｄ２２嵌合抗原受體及其用途
|
|
EP4108247A1
(en)
|
2021-06-23 |
2022-12-28 |
Ostravska univerzita |
Urine progenitor cells for use in cancer therapy
|
|
KR20240055714A
(ko)
*
|
2021-07-09 |
2024-04-29 |
레전드 바이오테크 아일랜드 리미티드 |
돌연변이 il-15 조성물 및 이의 방법
|
|
US20250145693A1
(en)
*
|
2021-09-18 |
2025-05-08 |
Sunnybay Biotech, Inc. |
Herv-k antibody, cell, vaccine, and drug therapeutics
|
|
AU2022366987A1
(en)
|
2021-10-14 |
2024-05-16 |
Arsenal Biosciences, Inc. |
Immune cells having co-expressed shrnas and logic gate systems
|
|
EP4180049A1
(en)
|
2021-11-16 |
2023-05-17 |
Ostravska univerzita |
Therapeutic composition for cancer treatment
|
|
US20250145950A1
(en)
*
|
2022-02-01 |
2025-05-08 |
Alaunos Therapeutics, Inc. |
Methods for Activation and Expansion of T Cells
|
|
US20230296610A1
(en)
*
|
2022-02-15 |
2023-09-21 |
Kite Pharma, Inc. |
Predicting adverse events from immunotherapy
|
|
WO2023173137A1
(en)
*
|
2022-03-11 |
2023-09-14 |
Yale University |
Compositions and methods for efficient and stable genetic modification of eukaryotic cells
|
|
WO2023194911A1
(en)
*
|
2022-04-04 |
2023-10-12 |
Gammadelta Therapeutics Ltd |
Cells expressing an anti-mesothelin car
|
|
WO2023194915A1
(en)
|
2022-04-04 |
2023-10-12 |
Gammadelta Therapeutics Ltd |
Novel gene armoring
|
|
WO2023217796A1
(en)
|
2022-05-10 |
2023-11-16 |
Miltenyi Biotec B.V. & Co. KG |
Compositions comprising il-15, il-15 receptor alpha and the intracellular signaling domain of cd2 for immune cell therapy
|
|
CA3253031A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Kite Pharma, Inc. |
NON-VIRAL ADMINISTRATION OF CELL THERAPY CONSTRUCTIONS
|
|
CA3257650A1
(en)
|
2022-06-08 |
2023-12-14 |
Century Therapeutics, Inc. |
Immunoeffector cells derived from genetically modified, multipotential stem cells with membrane IL-12 and their uses
|
|
CN115807020A
(zh)
*
|
2022-09-23 |
2023-03-17 |
卡瑞济(北京)生命科技有限公司 |
白介素15受体α装甲CAR-T细胞在降低白介素15诱导的细胞毒性中的用途
|
|
CN120344250A
(zh)
*
|
2022-10-25 |
2025-07-18 |
美商凯维那医疗公司 |
使用抗cd19 car-t细胞疗法治疗狼疮性肾炎的方法
|
|
WO2024102838A1
(en)
|
2022-11-09 |
2024-05-16 |
Century Therapeutics, Inc. |
Engineered interleukin-7 receptors and uses thereof
|
|
KR20250143301A
(ko)
|
2022-11-10 |
2025-10-01 |
센츄리 쎄라퓨틱스 인코포레이티드 |
항-넥틴4 키메라 항원 수용체를 갖는 유전자 조작 세포 및 이의 용도
|
|
CN120265664A
(zh)
*
|
2022-11-25 |
2025-07-04 |
苏州沙砾生物科技有限公司 |
一种融合多肽及其用途
|
|
CN115873803B
(zh)
*
|
2022-11-28 |
2025-06-17 |
上海恩凯细胞技术有限公司 |
提高nk细胞存活和抗肿瘤活性的方法及应用
|
|
WO2024150828A1
(ja)
*
|
2023-01-12 |
2024-07-18 |
積水化学工業株式会社 |
遺伝子導入方法
|
|
WO2024153124A1
(zh)
*
|
2023-01-18 |
2024-07-25 |
南京传奇生物科技有限公司 |
经修饰的原代t细胞及其用途
|
|
CN116287201A
(zh)
*
|
2023-02-13 |
2023-06-23 |
河南大学 |
一种肺动脉高压标志物tcf-7基因或tcf-7蛋白及其应用
|
|
WO2025059162A1
(en)
|
2023-09-11 |
2025-03-20 |
Dana-Farber Cancer Institute, Inc. |
Car-engager containing il-2 variants to enhance the functionality of car t cells
|
|
WO2025101938A2
(en)
|
2023-11-10 |
2025-05-15 |
Century Therapeutics, Inc. |
Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof
|
|
WO2025106626A1
(en)
|
2023-11-15 |
2025-05-22 |
Century Therapeutics, Inc. |
Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof
|
|
WO2025226918A1
(en)
*
|
2024-04-24 |
2025-10-30 |
La Jolla Institute For Immunology |
Herv-k envelope protein binders and compositions and methods of use thereof
|
|
WO2026043482A1
(en)
*
|
2024-08-21 |
2026-02-26 |
Fenwal, Inc. |
Modified cells produced by a modular biological cell processing system
|
|
CN120365387B
(zh)
*
|
2025-06-25 |
2025-08-29 |
海南大学三亚南繁研究院 |
一种植物免疫诱抗蛋白EqBPIE1及其应用
|